×
This post has expired! It was posted more than 90 days ago.
<- Back

148680 - The case for leaving out A1 beta-casein (Clinical Brief Series)

  • : Online

A four-part newsletter series on the difference between A1 and A2 beta-casein proteins. This Clinical Brief 4-part series will explore the evidence for improving patient health outcomes through the absence of A1 beta-casein.

Relevance to General Practice

Beta-casein, a major protein component of cows’ milk, has two main variants: A1 and A2 beta-casein. Studies have shown that milk containing A1 beta-casein is associated with gastrointestinal disturbances and other adverse health outcomes. This Clinical Brief series will explore the effects of A1 beta-casein on human health, the effect of A1 beta-casein on digestion in adults and children, the evidence for A1 beta-casein and its BCM-7 derivative as causative triggers of type 1 diabetes and cardiovascular disease and will also explore a case study of a patient with self-diagnosed milk intolerance.

Learning outcomes
  • Evaluate the evidence regarding the effects of A1 beta-casein on digestion
  • Recognise that many people with self-reported milk intolerance may have milk-related gastrointestinal symptoms due to ingestion of A1 beta-casein, as opposed to
  • Analyse the evidence on the association between A1 beta-casein and non-communicable diseases such as type 1 diabetes and cardiovascular disease
  • Review the alternatives to A1 beta-casein and their safety
  • Delivery
    Title
    148680 - The case for leaving out A1 beta-casein (Clinical Brief Series)
    Location
    Provider Type
    Education Provider
    Duration
    1 hour
    Start Date
    25-Apr-2019
    End Date
    31-Dec-2019
    CPD
    1 hour
    Price
    0.00
    Location
    Online
    Contact Phone
    Log in into view this field.
    HealthcareLink